千金药业：2025年上半年净利润同比增长8.50%

Group 1 - The company's operating revenue for the first half of 2025 is 1.818 billion yuan, a year-on-year decrease of 5.52% [1] - The net profit is 128 million yuan, showing a year-on-year increase of 8.50% [1] - The basic earnings per share is 0.3012 yuan, reflecting a year-on-year growth of 8.46% [1]